glp-1 receptor agonists adverse effects Safety and Tolerability of Glucagon-Like Peptide-1 Agonists: A State-of-the-Art Narrative Review | Drugs Gastrointestinal effect and adverse effects
Description
For comparison, the SURMOUNT-1 trial for tirzepatide showed an average of 20.9% weight loss at the highest dose over 72 weeks

doi: 10.1016/J.OPHTHA.2024.08.023 81 CheungNMitchellPWongTY

DCA, deoxycholic acid
By lowering inflammatory markers and oxidative stress

While the new pricing of GLP-1s would bring down that cost, it would still be relatively higher for GLP-1 users

Lets dig into how and why these medications are effective